Sareum Holdings plc (LON:SAR – Get Free Report)’s share price passed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 29.92 ($0.38) and traded as low as GBX 26.56 ($0.33). Sareum shares last traded at GBX 26.65 ($0.33), with a volume of 25,737 shares traded.
Sareum Stock Down 1.3 %
The stock has a market capitalization of £28.77 million, a PE ratio of -444.17 and a beta of -1.08. The stock has a fifty day moving average of GBX 26.09 and a 200-day moving average of GBX 29.70.
About Sareum
Sareum Holdings plc, a clinical stage small molecule drug development company, engages in the discovery and development of therapeutic drugs for cancer and autoimmune diseases. It develops small molecule therapeutic drugs based on its Sareum Kinase Inhibitor Library drug discovery platform. The company's lead product is SDC-1801, a TYK2/JAK1 inhibitor that is in a Phase 1a clinical trials for the treatment of autoimmune diseases.
Further Reading
- Five stocks we like better than Sareum
- What is an Earnings Surprise?
- Top 3 Investment Themes to Watch for in 2025
- Stock Market Sectors: What Are They and How Many Are There?
- Mega Buybacks in 2025: Why These 3 Leading Stocks Are Buys
- What Are the FAANG Stocks and Are They Good Investments?
- AMD vs. NVIDIA: The Better Semiconductor Bet for 2025
Receive News & Ratings for Sareum Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sareum and related companies with MarketBeat.com's FREE daily email newsletter.